Full Text View
Tabular View
No Study Results Posted
Related Studies
Insulin Secretory Capacity in Insulin-Independent Pancreas-Kidney Recipients Compared to Controls
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2008 by University Hospital, Gasthuisberg.   Recruitment status was  Recruiting

First Received on February 6, 2008.   No Changes Posted
Sponsor: University Hospital, Gasthuisberg
Collaborators: Juvenile Diabetes Research Foundation
Fund for Scientific Research, Flanders, Belgium
Information provided by: University Hospital, Gasthuisberg
ClinicalTrials.gov Identifier: NCT00618761
  Purpose

To compare functional beta-cell mass using the hyperglycaemic clamp test in insulin-independent pancreas-kidney recipients with that in non-diabetic kidney recipients and normal controls as well as with the partially previously reported data in beta-cell recipients.


Condition Intervention
Kidney Transplantation
Pancreas Transplantation
Other: hyperglycemic clamp test

Study Type: Interventional
Study Design: Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Insulin Secretory Capacity in Insulin-Independent Pancreas-Kidney Recipients Compared to Non-Diabetic Kidney Recipients, Insulin Independent Recipients of Beta-Cell Grafts and Healthy Controls.

Resource links provided by NLM:


Further study details as provided by University Hospital, Gasthuisberg:

Primary Outcome Measures:
  • insulin secretion during clamp test [ Time Frame: date of inclusion ] [ Designated as safety issue: No ]

Estimated Enrollment: 40
Study Start Date: October 2004
Estimated Study Completion Date: January 2010
Estimated Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
kidney-pancreas recipients
Other: hyperglycemic clamp test
hyperglycemic clamp test
Active Comparator: 2
kidney recipients
Other: hyperglycemic clamp test
hyperglycemic clamp test
Active Comparator: 3
healthy controls
Other: hyperglycemic clamp test
hyperglycemic clamp test
Active Comparator: 4
beta-cell recipients
Other: hyperglycemic clamp test
hyperglycemic clamp test

  Eligibility

Ages Eligible for Study:   21 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • kidney pancreas recipients
  • kidney recipients
  • healthy volunteers
  • beta-cell recipients
  • immunosuppression with MMF-Tacrolimus
  • 1-4 years after transplantation

Exclusion Criteria:

  • high doses of steroids
  • insulin dependent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00618761

Contacts
Contact: Chantal Mathieu, M.D., PhD. 0032/16/346994 chantal.mathieu@uz.kuleuven.ac.be

Locations
Belgium
Department of Endocrinology, Leuven, UZ-Gasthuisberg Recruiting
Leuven, Belgium, 3000
Contact: Pieter Gillard, M.D.     003216346994     pieter.gillard@uz.kuleuven.ac.be    
Sub-Investigator: Pieter Gillard, M.D.            
Sponsors and Collaborators
University Hospital, Gasthuisberg
Juvenile Diabetes Research Foundation
Fund for Scientific Research, Flanders, Belgium
Investigators
Principal Investigator: Chantal Mathieu, M.D., PhD UZ-Gasthuisberg, Department of Endocrinology
  More Information

No publications provided

Responsible Party: Prof. Dr. Chantal Mathieu, department of endocrinology, UZ Gasthuisberg, Leuven
ClinicalTrials.gov Identifier: NCT00618761     History of Changes
Other Study ID Numbers: clamp01, JDRF 4/2005/1327
Study First Received: February 6, 2008
Last Updated: February 6, 2008
Health Authority: Belgium: Institutional Review Board

Keywords provided by University Hospital, Gasthuisberg:
glucose clamp
beta-cell

Additional relevant MeSH terms:
Insulin
Pancrelipase
Hypoglycemic Agents
Physiological Effects of Drugs
Pharmacologic Actions
Gastrointestinal Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on February 09, 2012